期刊文献+

HPLC法测定放射增敏剂苯并三嗪衍生物YABQ含量及有关物质

Determination of content and related substances of radiosensitizer benzotriazine derivatives YABQ by HPLC
原文传递
导出
摘要 目的建立测定放射增敏剂YABQ含量及有关物质的高效液相色谱检测方法。方法采用Diamonsil C_(18)(250 mm×4.6 mm,5μm)色谱柱;流动相为甲醇-0.1%甲酸(22∶78)等度洗脱;流速1.0 ml/min;检测波长266 nm;柱温30℃;进样体积10μl。结果运用上述色谱方法进行检测,YABQ在7-84μg/ml的范围内线性关系良好(r=0.9992);该化合物检测限响应值为8 ng(信噪比S/N≥3),定量限响应值为24 ng(信噪比S/N≥10);经破坏性试验,各色谱峰间分离度良好(〉1.5),说明该色谱法满足试验要求。结论经方法学验证及破坏性试验,该法精密度高,专属性良好,可用于YABQ及其有关物质的质量控制。 Objective To establish an HPLC method for determination of the content of radiosensitizer YABQ and its related substances. Methods Diamonsil C18column( 250 mm × 4. 6 mm,5 μm) was used. The mobile phase consisted of methanol- 0. 1% formic acid( 22∶ 78) and isocratic elution at a flow rate of 1. 0 ml / min. The detection wavelength was 266 nm,the temperature of the column was 30℃,and the injection volume was 10 μl. Results The linear range of YABQ was7- 84 μg / ml,r = 0. 9992. The detection limit was 8 ng( S / N≥3),and the quantitation limit was 24 ng( S / N≥10).According to destructive sample processing,the separation coefficient between the peaks was above 1. 5,indicating that this chromatographic method could meet the YABQ monitoring requirements. Conclusion Method validation and destructive testing show that both the precision and specificity are fine with this method,which could be used for quality control of YABQ and its related substances.
出处 《军事医学》 CAS CSCD 北大核心 2016年第8期639-642,共4页 Military Medical Sciences
基金 国家自然科学基金资助项目(21375147) 国家科技重大新药创制专项资助项目(2013ZX09102-016)
关键词 含量测定 辐射增敏药 YABQ 质量控制 高效液相色谱法 苯并三嗪 quantitative analysis radiation-sensitizing agents YABQ quality control HPLC benzotriazine
  • 相关文献

参考文献8

  • 1赫捷,赵平,陈万青.2012年中国肿瘤登记年报[M].北京:军事医学科学出版社,2012.56-59.
  • 2.郑秀龙,金-尊,沈瑜.肿瘤治疗增敏药[M].上海:上海科学技术文献出版社,2011:1-85.
  • 3Kortmansky J, Schwartz GK. Bryostatin-1 : a novel PKC inhibitor in clinical development[J]. Cancer Invest, 2003, 21 (6): 924-936.
  • 4Bayman N], Blackball F, McCloskey P, et al. How can we optimise concurrent chemoradiotherapy for inoperable stage ]][ non-small cell lung cancer[J]. Lung Cancer, 2014, 83(2) : 117 -125.
  • 5von Pawel J, yon Roemeling R, Gatzemeier U, et al. Tirapazamine plus cisplatin versus cisplatin in advanced non-small-cell lung cancer: A report of the International CATAPULT I Study group [J]. J Clin Oncol, 2000, 18(6) : 1351 -1359.
  • 6江曼,钱晓萍,刘宝瑞.恶性肿瘤放射增敏剂研究进展[J].现代肿瘤医学,2014,22(1):226-228. 被引量:26
  • 7申冬妮,杨建云,肖炳坤,黄荣清.RP-HPLC法测定DHEA衍生物的含量及其有关物质[J].现代科学仪器,2013,30(2):124-125. 被引量:4
  • 8郑芸,吴敬波.肿瘤化疗增敏剂的研究现状及应用进展[J].西南军医,2010,12(3):506-508. 被引量:3

二级参考文献35

共引文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部